BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15734866)

  • 1. Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs.
    Ader M; Kim SP; Catalano KJ; Ionut V; Hucking K; Richey JM; Kabir M; Bergman RN
    Diabetes; 2005 Mar; 54(3):862-71. PubMed ID: 15734866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them.
    Park S; Sang Mee Hong ; Il Sung Ahn ; Sung Hoon Kim
    J Psychopharmacol; 2010 Jul; 24(7):1105-14. PubMed ID: 19965940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.
    Hatta K; Otachi T; Fujita K; Morikawa F; Ito S; Tomiyama H; Abe T; Sudo Y; Takebayashi H; Yamashita T; Katayama S; Nakase R; Shirai Y; Usui C; Nakamura H; Ito H; Hirata T; Sawa Y;
    Schizophr Res; 2014 Sep; 158(1-3):213-22. PubMed ID: 25086659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels.
    Roerig JL; Steffen KJ; Mitchell JE; Crosby RD; Gosnell BA
    J Clin Psychopharmacol; 2008 Feb; 28(1):21-6. PubMed ID: 18204336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia.
    Ryan MC; Flanagan S; Kinsella U; Keeling F; Thakore JH
    Life Sci; 2004 Mar; 74(16):1999-2008. PubMed ID: 14967195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance.
    Martins PJ; Haas M; Obici S
    Diabetes; 2010 Oct; 59(10):2418-25. PubMed ID: 20682682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study.
    Wampers M; Hanssens L; van Winkel R; Heald A; Collette J; Peuskens J; Reginster JY; Scheen A; De Hert M
    Eur Neuropsychopharmacol; 2012 Jan; 22(1):17-26. PubMed ID: 21511441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
    Fell MJ; Anjum N; Dickinson K; Marshall KM; Peltola LM; Vickers S; Cheetham S; Neill JC
    Psychopharmacology (Berl); 2007 Oct; 194(2):221-31. PubMed ID: 17581744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
    Fell MJ; Neill JC; Anjum N; Peltola LM; Marshall KM
    J Psychopharmacol; 2008 Mar; 22(2):182-6. PubMed ID: 18308803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.
    Pillai A; Parikh V; Terry AV; Mahadik SP
    J Psychiatr Res; 2007 Aug; 41(5):372-86. PubMed ID: 16564057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors.
    Roerig JL; Mitchell JE; de Zwaan M; Crosby RD; Gosnell BA; Steffen KJ; Wonderlich SA
    J Clin Psychopharmacol; 2005 Oct; 25(5):413-8. PubMed ID: 16160615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole.
    Shertzer HG; Kendig EL; Nasrallah HA; Johansson E; Genter MB
    Int J Obes (Lond); 2010 Jun; 34(6):970-9. PubMed ID: 20065957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally disintegrating olanzapine induces less weight gain in adolescents than standard oral tablets.
    Crocq MA; Guillon MS; Bailey PE; Provost D
    Eur Psychiatry; 2007 Oct; 22(7):453-4. PubMed ID: 17761403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Dosing of Risperidone and Olanzapine in the Maintenance Treatment for Patients With Schizophrenia and Related Psychotic Disorders: A Retrospective Multicenter Study.
    Yoshimura Y; Takeda T; Kishi Y; Harada T; Nomura A; Washida K; Yoshimura B; Sato K; Yada Y; Aoki S
    J Clin Psychopharmacol; 2017 Jun; 37(3):296-301. PubMed ID: 28306616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The atypical antipsychotics quetiapine, risperidone and ziprasidone do not increase insulin release in vitro.
    Melkersson K; Jansson E
    Neuro Endocrinol Lett; 2005 Jun; 26(3):205-8. PubMed ID: 15990722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers.
    Silverman BL; Martin W; Memisoglu A; DiPetrillo L; Correll CU; Kane JM
    Schizophr Res; 2018 May; 195():245-251. PubMed ID: 29158012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.
    Cooper GD; Pickavance LC; Wilding JP; Harrold JA; Halford JC; Goudie AJ
    J Psychopharmacol; 2007 Jun; 21(4):405-13. PubMed ID: 17050655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute insulin response and beta-cell compensation in normal subjects treated with olanzapine or risperidone for 2 weeks: response to Hardy et al.
    Jindal RD
    Diabetes Care; 2007 Jul; 30(7):e69; author reply e70. PubMed ID: 17596492
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia.
    Johnson DE; Yamazaki H; Ward KM; Schmidt AW; Lebel WS; Treadway JL; Gibbs EM; Zawalich WS; Rollema H
    Diabetes; 2005 May; 54(5):1552-8. PubMed ID: 15855345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.